Resistance Training for Heart Failure Patients Waiting for a Heart Transplant
Tests a resistance training program in hospitalized adults with heart failure waiting for transplant.
Plain-language title generated from the registry record
Registry title: Effect of Resistance Training in Patients on the Waiting List for Heart Transplant
Key facts
- Where
- São Paulo, BrazilSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 70 years old?
Source: NCT06426173, who can take part
Where in Brazil
- Instituto do Coração - Hospital das Clínicas da Faculdade de Medicina da Universidade de São PauloSão Paulo, BrazilTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Sao Paulo General Hospital
- Trial code
- NCT06426173
- Record updated
- 22 June 2026
- Original description
The present longitudinal, randomized, and blinded clinical trial aims to:Read full original descriptionShow less
Effect of Resistance Training on Functional Capacity, Quality of Life and Cardiac Biomarkers in Patients on the Waiting List for Heart Transplant: a Randomized and Controlled Clinical Trial
The present longitudinal, randomized, and blinded clinical trial aims to:
* Evaluate the effects of resistance training on the functional capacity, quality of life, and cardiac biomarkers of hospitalized patients with heart failure (HF) on the waiting list for heart transplantation (HTx). * Evaluate the associations between Fried's frailty classification and functional capacity responses to resistance training.
The protocol will have a total duration of 12 weeks.
Inclusion: patients included in heart transplant list ≤1 month; hemodynamically stable in the last 48 hours defined as mean arterial pressure (MAP) ≥ 60 mmHg and ≤ 120 mmHg and - Heart rate (HR) ≥ 60 bpm and ≤ 120 mmHg; dobutamine dose ≤ 10 mcg/kg/min.
Exclusion: heart failure of arrhythmogenic and/or restrictive etiology; presence of uncontrolled acute arrhythmias; cognitive, orthopedic, or neuromotor changes that prevent functional tests from being carried out.